Norovirus cases on the rise; stomach ailment often targets seniors
By
Alicia Lasek
Feb 12, 2023
Cases of norovirus infection, a common scourge of long-term care facilities, have risen steadily across the US in recent months, CDC data show.
FDA may authorize half-dose booster of Moderna’s coronavirus vaccine
By
Alicia Lasek
Sep 30, 2021
A 50-microgram dose appears to be effective enough to increase waning vaccine protection, and may reduce the risk of side effects, sources tell investigators.
Diabetes indicators improve with use of health incentives, CDC study finds
By
Alicia Lasek
Nov 10, 2022
Incentivizing patients to follow a lifestyle modification program helps them to improve a full range of diabetes-related health measures, according to a new meta-analysis.
Stanford to test antiviral pills as long COVID treatment
By
Alicia Lasek
Nov 28, 2022
Investigators plan to test whether the antiviral drug Paxlovid will relieve symptoms of the syndrome known as long COVID, also called post-acute sequelae of COVID-19.
New COVID booster shot rollout expected near Labor Day: officials
By
Alicia Lasek
Aug 25, 2022
The FDA expects to soon authorize omicron-targeting shots. The White House is planning to distribute them as part of a fall vaccination campaign, federal officials say.
FDA greenlights first home COVID test with traditional premarket review
By
Alicia Lasek
Jun 07, 2023
The Cue COVID-19 Molecular Test is the first at-home COVID-19 test to be granted marketing authorization outside of emergency use authorities, representing a new era of consumer access to diagnostic tests,...
New data show high excess mortality from RSV, reduced threat from flu among older adults
By
Alicia Lasek
Mar 02, 2022
The first such study in 13 years finds nuanced changes in the risk that flu and respiratory syncytial virus pose to seniors, and underscores the impact of the 2009 H1N1 flu pandemic on infections and deaths...
COVID shot boosters for all adults will help to reduce confusion, FDA says
By
Alicia Lasek
Nov 22, 2021
The FDA “heard loud and clear” that a simpler booster strategy was needed, its vaccine chief says. But the action may be too late to head off a winter virus surge, observers say.
Fed’s booster OK too late? Nursing home loses 8 to coronavirus outbreak this fall
By
Alicia Lasek
Nov 17, 2021
A Connecticut nursing home has weathered a facility-wide COVID-19 outbreak that has sickened 89 residents and staff. Booster shots were not yet authorized when the first cases appeared, the operator reports.
FDA advisers vote unanimously to endorse Novavax’s COVID-19 vaccine
By
Alicia Lasek (f3)
Jun 08, 2022
Independent advisers have voted 21 to 0 to recommend the authorization of Novavax’s COVID-19 protein-based vaccine for pandemic emergency use.